Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
AbCellera Biologics Inc.
abcellera.comAI Executive Summary
AI-powered analysis of 8-K filing content
AbCellera Biologics announced a strategic collaboration with Vertex Pharmaceuticals to jointly research, develop, manufacture, and commercialize multispecific T-cell engagers for autoimmune diseases, leveraging AbCellera's proprietary platform for discovery and early development.
Key Takeaways
AbCellera has secured a major partnership with Vertex Pharmaceuticals, a large pharmaceutical company, validating its T-cell engager platform technology
The collaboration focuses on multispecific T-cell engagers targeting autoimmune diseases and other conditions, expanding AbCellera's therapeutic reach
2 more takeaways
Related Filings (4)
4 more filings from AbCellera Biologics Inc. in the last 90 days